Prediction of<sup>177</sup>Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
Magdalena Mileva(Université Libre de Bruxelles), Ioannis Karfis(Institut Jules Bordet), Clémentine Marin(Université Libre de Bruxelles), Marianne Paesmans(Université Libre de Bruxelles), Alain Hendlisz(London Cancer), Rachele Danieli(Université Libre de Bruxelles), Hugo Levillain(Université Libre de Bruxelles), Amélie Deleporte(Université Libre de Bruxelles), Maria Antonietta Bali(Royal Marsden NHS Foundation Trust), Gabriela Critchi(Université Libre de Bruxelles), Chloé Velghe(Université Libre de Bruxelles), Lieveke Ameye(KU Leuven), Patrick Flamen(Université Libre de Bruxelles), Camille Van Bogaert(Université Libre de Bruxelles), Zéna Wimana(Institut Jules Bordet), Carlos Artigas, Christiane Jungels(Université Libre de Bruxelles), Loubna Taraji-Schiltz(Université Libre de Bruxelles), Konstantinos Stathopoulos(Institut Jules Bordet), Simona Picchia(Royal Marsden NHS Foundation Trust), Bruno Vanderlinden(Université Libre de Bruxelles), Gwennaëlle Marin(Université Libre de Bruxelles)
Cited by 52
Related Papers
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
|British Journal of Cancer|2007|957